Disease Category Listing (62): Epilepsy

Clinical Trials: Epilepsy

Alabama

Alabaster; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Birmingham; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Birmingham; University of Alabama
RNS™ System Pivotal Clinical Investigation

Huntsville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Northport; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Alaska

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Arizona

Phoenix; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Phoenix; Lovelace Scientific Resources - AZ
Do you or some you know have epilepsy?

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Arkansas

Little Rock; Clinical Trials, Inc
Epilepsy and non-controlled partial seizures

Little Rock; Clinical Trials, Inc.
Refractory Epilepsy and acute repetitive seizures (ARS)

Little Rock; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Little Rock; Clinical Trials, Inc.
Epilepsy and non-controlled partial seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

California

Costa Mesa; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

La Jolla; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Los Angeles; University of Southern California
RNS™ System Pivotal Clinical Investigation

Oxnard; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Sacramento; Sutter Institute for Medical Research (SIMR)
Epilepsy: Refractory Partial Seizures

Sacramento; Sutter Institute for Medical Research (SIMR)
Epilepsy: Acute Repetitive Seizures

San Diego; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

San Francisco; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

San Francisco; California Pacific Medical Center
RNS™ System Pivotal Clinical Investigation

Santa Monica; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Sylmar; UCLA Medical Center
Trigeminal Nerve Stimulation for Epilepsy

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Colorado

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Connecticut

Fairfield; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

New Haven; Yale University School of Medicine
RNS™ System Pivotal Clinical Investigation

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Delaware

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Florida

Gainesville; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Gainesville; University of Florida
RNS™ System Pivotal Clinical Investigation

Maitland; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Orlando; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Panama City; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Sarasota; UCB Clinical Trial Call Center [*]
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Sarasota; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Sarasota; Lovelace Scientific Resources - Sarasota
Epilepsy

Tallahassee; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Georgia

Atlanta; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Atlanta; Neurotrials Research, Inc.
Do you suffer from Seizures?

Augusta; Medical College of Georgia
RNS™ System Pivotal Clinical Investigation

Canton; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Savannah; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Hawaii

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Idaho

Boise; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Illinois

Chicago; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Springfield; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Indiana

Fort Wayne; UCB Clinical Trial Call Center [*]
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures

Indianapolis; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Indianapolis; Indiana University
RNS™ System Pivotal Clinical Investigation

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Iowa

Ames; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Kansas

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Wichita; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Wichita; Via Christi Comprehensive Epilepsy Center
RNS™ System Pivotal Clinical Investigation

Kentucky

Louisville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Louisiana

New Orleans; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Maine

Scarborough; UCB Clinical Trial Call Center [*]
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Maryland

Baltimore; UCB Clinical Trial Call Center [*]
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Baltimore; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Baltimore; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures

Baltimore; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.

Baltimore; Johns Hopkins University
RNS™ System Pivotal Clinical Investigation

Bethesda; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Pikesville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Massachusetts

Boston; Massachusetts General Hospital (MGH)
Genotype and Phenotype of Brainstem Injury in Autism, Project IV: Gene-environment interactions in a population exposed to a teratogen associated with autism

Boston; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Boston; Massachusetts General Hospital
RNS™ System Pivotal Clinical Investigation

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Michigan

Detroit; UCB Clinical Trial Call Center [*]
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Detroit; Henry Ford Hospital
RNS™ System Pivotal Clinical Investigation

Grand Rapids; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Minnesota

Golden Valley; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Minneapolis; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Mississippi

Hattiesburg; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Missouri

Chesterfield; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Chesterfield; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Chesterfield; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.

Chesterfield; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures

St Louis; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Montana

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Nebraska

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Nevada

Henderson; Lovelace Scientific Resources, Inc.
Lamotrigine Extended-Release in Elderly Patients with Epilepsy

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

New Hampshire

Lebanon; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Lebanon; Dartmouth-Hitchcock Medical Center
RNS™ System Pivotal Clinical Investigation

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

New Jersey

Edison; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Voorhees; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

New Mexico

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

New York

Albany; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Bronx; Biomedical Research Alliance of New York
Refractory Partial Seizures-Adults and Minors

Bronx; Biomedical Research Alliance of New York
Photosensitivity Study - Adults

Buffalo; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Buffalo; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy

Buffalo; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Cedarhurst; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

New Hyde Park; Biomedical Research Alliance of New York
Refractory Partial Seizures

New York; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

New York; Biomedical Research Alliance of New York
Epilepsy consisting of uncontrolled partial-onset seizures - Adults

New York; Biomedical Research Alliance of New York
Refractory Partial Seizures

New York; Columbia University Medical Center
Multicenter Genetic Study of Rolandic Epilepsy

New York; Biomedical Research Alliance of New York
Refractory Partial Seizures

New York; Biomedical Research Alliance of New York
Epilepsy

Rochester; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Rochester; University of Rochester
RNS™ System Pivotal Clinical Investigation

Syracuse; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

North Carolina

Asheville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Durham; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Salisbury; UCB Clinical Trial Call Center [*]
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Winston-Salem; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

North Dakota

Bismarck; Odyssey Research Services
An Epilepsy Research Study

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Ohio

Cleveland; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Cleveland; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures

Cleveland; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.

Columbus; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Columbus; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.

Columbus; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures

Toledo; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Oklahoma

Tulsa; UCB Clinical Trial Call Center [*]
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Oregon

Medford; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Portland; Oregon Health & Sciences University
RNS™ System Pivotal Clinical Investigation

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Pennsylvania

Bethlehem; UCB Clinical Trial Call Center [*]
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures

Philadelphia; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy

Philadelphia; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Tarentum; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Rhode Island

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

South Carolina

Beaufort; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

South Dakota

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Tennessee

Nashville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Nashville; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Nashville; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.

Nashville; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures

Nashville; Access Clinical Trials, Inc. - Nashville
Epilepsy and Partial-onset Seizures. Do You Or Someone You Know Have Epilepsy?

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Texas

Dallas; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Dallas; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.

Dallas; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures

El Paso; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Fort Worth; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy

Fort Worth; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Houston; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Houston; Baylor College of Medicine
RNS™ System Pivotal Clinical Investigation

Temple; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Utah

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Vermont

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Virginia

Charlottesville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Charlottesville; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Charlottesville; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.

Charlottesville; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Charlottesville; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures

Richmond; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Richmond; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Washington

Renton; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Seattle; Swedish Medical Center
RNS™ System Pivotal Clinical Investigation

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Washington, DC

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Washington; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Washington; George Washington University
RNS™ System Pivotal Clinical Investigation

West Virginia

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Wisconsin

Madison; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Madison; University of Wisconsin School of Medicine and Public Health
RNS™ System Pivotal Clinical Investigation

Milwaukee; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Milwaukee; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

Wyoming

Various Cities; Research Site
Lamotrigine Pregnancy Registry – examining pregnancy outcomes of women exposed to lamotrigine

International

Graz, Austria; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Graz, Austria; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Innsbrick, Austria; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Innsbrick, Austria; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Linz, Austria; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Linz, Austria; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Vienna, Austria; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Wien, Austria; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Antwerpen, Belgium; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Brugge, Belgium; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Brussels, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

EDEGEM, Belgium; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Gent, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy

Gent, Belgium; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Gent, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Gent, Belgium; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Godinne, Belgium; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Leuven, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy

Leuven, Belgium; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Leuven, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

LEUVEN, Belgium; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Liege, Belgium; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Liege, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Montignies Sur Sambre, Belgium; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Saint-Vith, Belgium; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Montreal, Quebec, Canada; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Quebec, QC, Canada; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Vancouver, BC, Canada; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Beroun, Czech Republic; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

BEROUN, Czech Republic; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Brno, Czech Republic; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

BRNO, Czech Republic; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Budejovice, Czech Republic; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

CESKE BUDEJOVICE, Czech Republic; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Ostrava Trebovice, Czech Republic; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Ostrava Trebovice, Czech Republic; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

PRAHA 1, Czech Republic; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Praha 2, Czech Republic; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

PRAHA 5, Czech Republic; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Praha 5, Czech Republic; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Zlin, Czech Republic; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Zlin, Czech Republic; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Helsinki, Finland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Kuopio, Finland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Kuopio, Finland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Oulu, Finland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Oulu, Finland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Oys, Finland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Seinajoki, Finland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Seinajoki, Finland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Tampere, Finland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Tampere, Finland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Tampere, Finland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Amiens, France; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Angers Cedex 1, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Angers Cedex 9, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Bethune, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Bethune, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Bron, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Bron, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Dijon, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Dijon, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Lille, France; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Lille, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Lyon, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Marseille, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Montpellier Cedex, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Montpellier Cedex 5, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Nancy, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Paris, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Paris, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Paris, France; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Paris, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Reims, France; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Reims, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Rennes, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Rennes, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Roanne, France; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Roanne, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

St Pierre Cedex, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Strasbourg, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Strasbourg, France; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Toulouse Cedex 04, France; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Bad Berka, Germany; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Berlin, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Berlin, Germany; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Berlin, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Berlin, Germany; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Bernau, Germany; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Bernau, Germany; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Bielefeld, Germany; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Bonn, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Erlangen, Germany; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Frankfurt, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Freiburg, Germany; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Freiburg, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Gottingen, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Göttingen, Germany; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Heidelberg, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy

Heidelberg, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Jena, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Jena, Germany; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Kehl, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy

Kehl, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Kehl, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Kehl, Kork, Germany; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Kiel, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy

Kiel, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Liegau-Augustusbad, Germany; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Mainz, Germany; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Munchen, Germany; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Munchen, Germany; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

München, Germany; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Münster, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Ulm, Germany; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Hong Kong, Hong Kong; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Budapest, Hungary; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Budapest, Hungary; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Debrecen, Hungary; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Debrecen, Hungary; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Pecs, Hungary; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Szeged, Hungary; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Zalaegerszeg, Hungary; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Bangalore, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Bangalore, India; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Hyderabad, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Hyderabad, India; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Jaipur, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Kolkata, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Lucknow, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Mumbai, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Mumbai, India; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

New Delhi, India; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Pune, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Pune Maharashtra, India; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Thiruvananthapuram, India; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Tirupati, India; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Tel Aviv, Israel; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Bari, Italy; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Bologna, Italy; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Bologna, Italy; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Foggia, Italy; UCB Clinical Trial Call Center [*]
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Messina, Italy; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Milano, Italy; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Milano, Italy; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Milano, Italy; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Napoli, Italy; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Pavia, Italy; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Perugia, Italy; UCB Clinical Trial Call Center [*]
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Roma, Italy; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Roma, Italy; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Roma, Italy; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Roma, Italy; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Siena, Italy; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Siena, Italy; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Breda, Netherlands; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Breda, Netherlands; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Den Haag, Netherlands; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Heemstede, Netherlands; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Heeze, Netherlands; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Maastricht, Netherlands; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Zwolle, Netherlands; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Bergen, Norway; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Fredrikstad, Norway; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Fredrikstad, Norway; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Oslo, Norway; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Oslo, Norway; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Sandvika, Norway; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Sandvika, Norway; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Trondheim, Norway; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Trondheim, Norway; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Bialystok, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Bialystok, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Gdansk, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Gdansk, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Katowice, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Katowice, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Kielce, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Kielce, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Lodz, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Lodz, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Lublin, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Lublin, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Szczecin, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Szczecin, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Warsaw, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Warsaw, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Warszawa, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Warszawa, Poland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Warszawa, Poland; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Kazan, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Moscow, Russian Federation; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Moscow, Russian Federation; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Moscow, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Samara, Russian Federation; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Samara, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

St. Petersburg, Russian Federation; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

St. Petersburg, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Yaroslavi, Russian Federation; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Belgrade, Serbia and Montenegro; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Singapore, Singapore; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Singapore, Singapore; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Cape Town, South Africa; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

George, South Africa; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Johannesburg, South Africa; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Tygeberg, South Africa; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Gwangju, South Korea; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Seoul, South Korea; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Alcorcon, Spain; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Barcelona, Spain; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Barcelona, Spain; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Madrid, Spain; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Madrid, Spain; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Madrid, Spain; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

San Sebastian, Spain; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Vigo, Spain; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Zaragoza, Spain; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Goteborg, Sweden; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Göteborg, Sweden; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Stockholm, Sweden; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Stockholm, Sweden; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Umea, Sweden; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Umea, Sweden; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Stockholm, Sweeden; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Biel, Switzerland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Geneve, Switzerland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

St Gallen, Switzerland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Tschugg, Switzerland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Zürich, Switzerland; UCB Clinical Trial Call Center
Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

La Manouba, Tunisia; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Tunis, Tunisia; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Donetsk, Ukraine; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Donetsk, Ukraine; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Kharkov, Ukraine; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Kharkov, Ukraine; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Kyiv, Ukraine; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Kyiv, Ukraine; UCB Clinical Trial Call Center [*]
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Kyiv, Ukraine; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Lviv, Ukraine; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Lviv, Ukraine; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Odessa, Ukraine; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Odessa, Ukraine; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Uzhgorod, Ukraine; UCB Clinical Trial Call Center
Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Uzhgorod, Ukraine; UCB Clinical Trial Call Center
Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]